Shenzhen Bioeasy (China) Today
| 300942 Stock | 8.79 0.31 3.66% |
Performance13 of 100
| Odds Of DistressLess than 23
|
Shenzhen Bioeasy is trading at 8.79 as of the 26th of November 2024, a 3.66% up since the beginning of the trading day. The stock's open price was 8.48. Shenzhen Bioeasy has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Shenzhen Bioeasy Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shenzhen Bioeasy is entity of China. It is traded as Stock on SHE exchange. The company has 400.87 M outstanding shares. More on Shenzhen Bioeasy Biotechnology
Moving together with Shenzhen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shenzhen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shenzhen Bioeasy's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shenzhen Bioeasy or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Shenzhen Bioeasy's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shenzhen Bioeasy's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShenzhen Bioeasy can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shenzhen Bioeasy's financial leverage. It provides some insight into what part of Shenzhen Bioeasy's total assets is financed by creditors.
| |||||
Shenzhen Bioeasy Biotechnology (300942) is traded on Shenzhen Stock Exchange in China and employs 389 people. Shenzhen Bioeasy is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shenzhen Bioeasy's market, we take the total number of its shares issued and multiply it by Shenzhen Bioeasy's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shenzhen Bioeasy Bio operates under Biotechnology sector and is part of Health Care industry. The entity has 400.87 M outstanding shares.
Shenzhen Bioeasy generates negative cash flow from operations
Check Shenzhen Bioeasy Probability Of Bankruptcy
Ownership AllocationShenzhen Bioeasy Bio shows a total of 400.87 Million outstanding shares. Shenzhen Bioeasy Bio has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.88 % of Shenzhen Bioeasy outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shenzhen Ownership Details
Shenzhen Bioeasy Bio Risk Profiles
Although Shenzhen Bioeasy's alpha and beta are two of the key measurements used to evaluate Shenzhen Bioeasy's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.19 | |||
| Semi Deviation | 3.75 | |||
| Standard Deviation | 4.33 | |||
| Variance | 18.73 |
Shenzhen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shenzhen Bioeasy without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Shenzhen Bioeasy Corporate Directors
| Zhaoli Xiao | Deputy Director | Profile | |
| Zhiying Chen | Deputy Director | Profile | |
| Wenhao Yan | Deputy Director | Profile | |
| Hehua Lu | GM Director | Profile |
Other Information on Investing in Shenzhen Stock
Shenzhen Bioeasy financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Bioeasy security.